María Helena López-Ceballos
Hospital San Pedro de Alcántara(ES)GEICAM – Spanish Breast Cancer Group(ES)
Publications by Year
Research Areas
Cancer Risks and Factors, BRCA gene mutations in cancer, PARP inhibition in cancer therapy, Breast Cancer Treatment Studies, Vitamin D Research Studies
Most-Cited Works
- → Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain(2018)38 cited
- → Molecular characterization of pregnancy-associated breast cancer and insights on timing from GEICAM-EMBARCAM study(2025)9 cited
- → Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study(2024)2 cited
- → Abstract PO2-13-05: Deciphering pregnancy-associated breast cancer: distinctive molecular profile and clinical implications from GEICAM/2017-07 EMBARCAM study(2024)1 cited
- → Abstract P4-07-29: Olaparib plus Trastuzumab in HER2[+] BRCA-Mutated Advanced Breast Cancer Patients: The OPHELIA Study(2023)
- → Utility of quantitative bone ultrasound to assess anastrozole effect on bone mass in patients with breast cancer(2011)